Blue Water Biotech Inc expected to post a loss of 14 cents a share - Earnings Preview

Onconetix

21/10/2023 01:38

* Blue Water Biotech Inc  BWV.OQ   BWV.O  is expected
to report
results
    * 
    * ​Refinitiv's mean analyst estimate for Blue Water Biotech
Inc is
for a loss of 14 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 25.0%
in the last three months. ​
    * Wall Street's median 12-month price target for Blue Water
Biotech Inc is $9​, above​ its last closing price of $0.41. ​​​

This summary was machine generated October 21 at 00:38 GMT.  All
figures in US dollars  unless otherwise stated